GPT Healthcare files DRHP with SEBI in second attempt to go public; check OFS, fresh issue details

livemint.com:

₹450-500 crore through the issue. The company had received the markets regulator's nod to float the issue but did not go ahead with the launch. According to the DRHP, the IPO comprises a fresh issue of equity shares aggregating to ₹40 crore, and an offer for sale of up to 2.6 crore equity shares by BanyanTree Growth Capital II, LLC, a Mauritius-based structured private equity.

Also Read: IRM Energy IPO opens tomorrow: GMP, issue details, 10 key things to know Currently, promoter GPT Sons holds a 67.34 per cent stake in GPT Healthcare, and the rest of the shareholding sits with BanyanTree Growth Capital. The company will utilise the proceeds from the fresh issue for payment of debt and general corporate purposes. JM Financial is the new and sole merchant banker for the issue, while Link Intime India is the registrar to the offer.

GPT Healthcare, operates and manages four full service multispecialty hospitals under the ILS Hospitals brand with a total capacity of 561 beds. It attends to over 35 specialties and super specialties such as internal medicine, diabetology, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurology, neurosurgery and paediatrics. According to the DRHP, the company competes with listed industry peers, including Global Health Ltd, Krishna Institute of Medical Sciences Ltd, Jupiter Life Line Hospitals Ltd, Yatharth Hospital & Trauma Care Services Ltd, Kovai Medical Center & Hospital Limited and Shalby Ltd.